NL · NL · NL-b052bd9ff50b

Livmarli 30 mg, tabletten

ATC A05AX04

Last synced from CBG-MEB (Netherlands) on June 9, 2026

Identification

ManufacturerMirum Pharmaceuticals International B.V.

CountryNL (NL)

ATC codeA05AX04

Dispensing—

ReimbursedNo

SourceCBG-MEB (Netherlands)

Last synced6/9/2026

Packs · 1

cbg_meb_id
EU/1/22/1704

Annotations

No annotations yet.

Raw payload (JSON)

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/livmarli-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Maralixibat chloride",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134245",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "GLYCEROLPALMITOSTEARAAT",
    "LACTOSE 1-WATER",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "MARALIXIBATCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/12/09",
  "procedure_number": "EMEA/H/C/005857",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1704",
  "additional_monitoring": "Y"
}

Related drugs

Other records sharing ATC code A05AX04.

Access this data programmatically

Query Livmarli 30 mg, tabletten and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs